Caracciolo E A, Chaitman B R, Forman S A, Stone P H, Bourassa M G, Sopko G, Geller N L, Conti C R
Cardiac Catheterization Laboratory, St Louis University Health Sciences Center, MO 63110, USA.
Circulation. 1996 Jun 15;93(12):2097-105. doi: 10.1161/01.cir.93.12.2097.
There are conflicting data as to whether diabetics have a higher prevalence of asymptomatic ST-segment depression during exercise treadmill testing (ETT) and ambulatory ECG (AECG) monitoring. This study was conducted to determine whether diabetic patients with coronary disease enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) have more episodes of asymptomatic ischemia during ETT and 48-hour AECG monitoring than nondiabetic patients and to compare differences in angiographic variables and the magnitude of ischemia as measured by standard ETT and AECG criteria.
Angiographic variables and the prevalence and magnitude of ischemia during the qualifying ETT and 48-hour AECG were compared by the presence and absence of diabetes mellitus in 558 randomized ACIP patients. Seventy-seven patients had a history of diabetes and were taking oral hypoglycemics or insulin (diabetic group); 481 patients did not meet these criteria (nondiabetic group). Multivessel disease (87% versus 74%, P = .01) was more frequent in the diabetic group. The percentages of patients without angina during the ETT were similar in the diabetic and nondiabetic groups (36% and 39%, respectively). Time to onset of > or = 1-mm ST-segment depression and time to onset of angina were similar in both groups. The percentages of patients with only asymptomatic ST-segment depression during the 48-hour AECG were similar in the diabetic and nondiabetic groups (94% versus 88%, respectively). However, total ischemic time per 24 hours (15.0 +/- 21.4 versus 23.6 +/- 31.1 minutes, P = .02), ischemic time per episode (6.3 +/- 4.6 versus 9.0 +/- 8.7 minutes, P < .01), and the maximum depth of ST-segment depression tended to be less in the diabetic group.
Patients enrolled in ACIP were selected on the basis of an abnormal ETT and 48-hour AECG and ability to undergo coronary revascularization. When patients with diabetes mellitus were compared with those without diabetes, there was a similar prevalence of asymptomatic ischemia during ETT and 48-hour AECG monitoring. Despite more extensive and diffuse coronary disease, diabetic ACIP patients tended to have less measurable ischemia during the 48-hour AECG.
关于糖尿病患者在运动平板试验(ETT)和动态心电图(AECG)监测期间无症状ST段压低的患病率,存在相互矛盾的数据。本研究旨在确定参加无症状心脏缺血试验(ACIP)的冠心病糖尿病患者在ETT和48小时AECG监测期间无症状缺血发作是否比非糖尿病患者更多,并比较血管造影变量以及通过标准ETT和AECG标准测量的缺血程度差异。
在558例随机分组的ACIP患者中,根据是否患有糖尿病比较血管造影变量以及在合格ETT和48小时AECG期间缺血的患病率和程度。77例患者有糖尿病史且正在服用口服降糖药或胰岛素(糖尿病组);481例患者不符合这些标准(非糖尿病组)。糖尿病组多支血管病变更常见(87%对74%,P = 0.01)。糖尿病组和非糖尿病组在ETT期间无胸痛的患者百分比相似(分别为36%和39%)。两组中ST段压低≥1mm的发作时间和胸痛发作时间相似。糖尿病组和非糖尿病组在48小时AECG期间仅有无症状ST段压低的患者百分比相似(分别为94%和88%)。然而,糖尿病组每24小时的总缺血时间(15.0±21.4对23.6±31.1分钟,P = 0.02)、每次发作的缺血时间(6.3±4.6对9.0±8.7分钟,P < 0.01)以及ST段压低的最大深度往往较低。
入选ACIP的患者是基于异常的ETT和48小时AECG以及进行冠状动脉血运重建的能力。当将糖尿病患者与非糖尿病患者进行比较时,在ETT和48小时AECG监测期间无症状缺血的患病率相似。尽管糖尿病ACIP患者的冠状动脉疾病更广泛和弥漫,但在48小时AECG期间可测量的缺血往往较少。